Ralliant Corporation $RAL Shares Purchased by Public Sector Pension Investment Board

Public Sector Pension Investment Board boosted its holdings in Ralliant Corporation (NYSE:RAL) by 14.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 439,714 shares of the company’s stock after acquiring an additional 55,237 shares during the quarter. Public Sector Pension Investment Board’s holdings in Ralliant were worth $19,229,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Dodge & Cox bought a new stake in shares of Ralliant in the 2nd quarter worth approximately $523,571,000. Viking Global Investors LP acquired a new position in Ralliant in the second quarter worth approximately $257,200,000. State Street Corp bought a new position in shares of Ralliant in the second quarter valued at $213,096,000. Flossbach Von Storch SE lifted its position in shares of Ralliant by 1.7% during the 3rd quarter. Flossbach Von Storch SE now owns 4,152,866 shares of the company’s stock valued at $181,605,000 after acquiring an additional 67,963 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Ralliant during the 2nd quarter worth $108,453,000.

Ralliant Price Performance

NYSE RAL opened at $44.03 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a market capitalization of $4.97 billion and a price-to-earnings ratio of 22.46. The company has a 50 day simple moving average of $50.79 and a 200-day simple moving average of $46.56. Ralliant Corporation has a 52-week low of $37.27 and a 52-week high of $57.02.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. The company’s revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio (DPR) is currently 10.20%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on RAL shares. Royal Bank Of Canada cut their target price on Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a research report on Friday, February 6th. Vertical Research raised shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a research note on Friday, February 6th. Truist Financial dropped their target price on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Morgan Stanley restated an “overweight” rating and issued a $45.00 price target on shares of Ralliant in a research report on Friday, February 6th. Finally, Zacks Research cut shares of Ralliant from a “hold” rating to a “strong sell” rating in a research report on Monday, February 9th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $50.50.

Insider Transactions at Ralliant

In other news, Director Kate Mitchell bought 2,350 shares of the stock in a transaction on Tuesday, February 10th. The shares were purchased at an average price of $42.48 per share, for a total transaction of $99,828.00. Following the completion of the purchase, the director directly owned 8,411 shares of the company’s stock, valued at $357,299.28. This trade represents a 38.77% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Anelise Angelino Sacks bought 2,000 shares of the company’s stock in a transaction on Monday, February 9th. The stock was purchased at an average cost of $41.25 per share, for a total transaction of $82,500.00. Following the completion of the transaction, the director owned 5,403 shares in the company, valued at approximately $222,873.75. The trade was a 58.77% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought a total of 8,145 shares of company stock worth $332,233 in the last ninety days.

More Ralliant News

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Directors/insiders bought stock this week (Kate Mitchell bought 2,350 shares at ~$42.48; Anelise Angelino Sacks bought ~2,000 shares), a signal often read as confidence in the company and a near‑term support for the share price. InsiderTrades: Kate Mitchell Acquires 2,350 Shares The Motley Fool: Director Scoops Up 2,000 Shares
• Neutral Sentiment: Recent quarterly results beat consensus (EPS and revenue) and the company provided Q1 and FY 2026 guidance — fundamentals remain mixed and will be watched closely but are not a new surprise. MarketBeat: Ralliant Earnings & Guidance
• Negative Sentiment: Multiple law firms have publicly opened or promoted investigations into possible securities‑law violations tied to Ralliant (Kaplan Fox, Kirby McInerney, Kessler Topaz, Block & Leviton and others). Those actions increase litigation and regulatory risk and can pressure the stock as legal costs, disclosures and management distraction unfold. Globe and Mail: Kaplan Fox Alert GlobeNewswire: Kirby McInerney Alert
• Negative Sentiment: Ongoing negative analyst moves, higher short interest and prior material non‑cash impairment/guidance reductions (reported earlier) raise downside risk and intraday volatility — these factors can offset positive insider signals and lead to further selling on adverse updates. Kessler Topaz PR Business Insider: Block & Leviton Alert

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.